Press Releases

Share
and/or
489 News Releases found
Craig D. Blinderman Named Chief of Supportive Care Service at Memorial Sloan Kettering Cancer Center
Craig D. Blinderman Named Chief of Supportive Care Service at Memorial Sloan Kettering Cancer Center
Dr. Blinderman is a national leader in supportive care.
Memorial Sloan Kettering Physician-Scientists Elected to the Prestigious National Academy of Medicine
Memorial Sloan Kettering Physician-Scientists Elected to the Prestigious National Academy of Medicine
Luis Diaz Jr., MD, Head of the Division of Solid Tumor Oncology, and incumbent of the Grayer Family Chair, and Kojo S.J. Elenitoba-Johnson, MD, Chair of the Department of Pathology and Laboratory Medicine, Member in the Human Oncology Pathogenesis Program (HOPP), and the incumbent of the James Ewing Alumni Chair of Pathology at Memorial Sloan Kettering Cancer Center (MSK), have been elected to the National Academy of Medicine (NAM), one of the highest honors bestowed upon scientists worldwide.
Scott Stuart, Chair of the Boards of Trustees and Governing Trustees at Memorial Sloan Kettering Cancer Center (MSK)
Scott Stuart Named a Notable Nonprofit Board Leader by Crain’s
Scott Stuart, Chair of the Boards of Trustees and Governing Trustees at Memorial Sloan Kettering Cancer Center (MSK), has been recognized as a Notable Nonprofit Board Leader in the 2023 Crain’s New York Business special editorial feature.
MSK Awards & Appointments January 2023
MSK Awards & Appointments September 2023
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Notice of Nuance MOVEit Incident
Memorial Sloan Kettering Cancer Center (MSK) was recently notified by one of our vendors, Nuance Communications, Inc. (“Nuance”), of a data security incident that affected Nuance.  The incident was related to Nuance’s use of the MOVEit file transfer software. The incident occurred at Nuance and did not affect any of MSK’s computing or information systems.
Michel Sadelain, MD, PhD
Memorial Sloan Kettering Cancer Center Physician-Scientist Michel Sadelain Awarded 2024 Breakthrough Prize in Life Sciences
Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that Michel Sadelain, MD, PhD, renowned physician-scientist, Director of the Center for Cell Engineering, and Stephen and Barbara Friedman Chair, has been awarded the 2024 Breakthrough Prize in Life Sciences.
Memorial Sloan Kettering Cancer Center Announces Visionary Gift From the Commonwealth Foundation for Cancer Research
Memorial Sloan Kettering Cancer Center (MSK) today announced a transformative gift from the Commonwealth Foundation for Cancer Research to benefit the Center for Experimental Therapeutics, a multidisciplinary research and drug development group at MSK. With this gift, the Commonwealth Foundation for Cancer Research continues their nearly three-decade commitment to the Center for Experimental Therapeutics, which was initially founded in 2002 with a generous gift from the Foundation.
MSK Awards & Appointments January 2023
MSK Awards & Appointments August 2023
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Students in the Cancer Engineering program will advance their research with support from state-of-the art core facilities including the Radiochemistry and Molecular Imaging Probes core.
Memorial Sloan Kettering Cancer Center’s Gerstner Sloan Kettering Graduate School of Biomedical Sciences Announces First-of-Its-Kind Cancer Engineering PhD Program
The Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) at Memorial Sloan Kettering Cancer Center (MSK) today announced The Pat and Ian Cook Doctoral Program in Cancer Engineering, made possible by a generous gift of $15 million from Pat and Ian Cook.
Memorial Sloan Kettering Cancer Center Issues Statement on Second Quarter 2023 Financial Results
Memorial Sloan Kettering Cancer Center (MSK) issued the following statement today regarding financial results for the six months ended June 30, 2023.
MSK Awards & Appointments January 2023
MSK Awards & Appointments July 2023
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Damon Reed
Damon Reed Named Division Head of Pediatric Solid Tumors and Chief of Pediatric Sarcoma Service at Memorial Sloan Kettering Cancer Center
Damon Reed, MD, has joined Memorial Sloan Kettering Cancer Center (MSK) as the inaugural Head of the Division of Pediatric Solid Tumors and as Chief of the Pediatric Sarcoma Service. Dr. Reed is a distinguished oncologist who has dedicated his career to cancer care for children, adolescents, and young adults. A gifted clinician-investigator, he is known for his work in advancing sarcoma clinical research.
a nurse and a patient
Memorial Sloan Kettering Cancer Center Ranked the Best Cancer Center in the Northeast and First in the Nation for Urology Care by U.S. News & World Report
Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the best cancer center in the northeast, the number two hospital for cancer care in the nation, and the number one hospital nationally for urology care by U.S. News & World Report in its annual Best Hospitals listing.
Memorial Sloan Kettering Cancer Center (MSK) today announced the launch of a new digital patient experience through MSK Direct, a national cancer benefits solution for self-insured employers, labor unions, and health plans.
Memorial Sloan Kettering Cancer Center Broadens Access to Its Cancer Care Expertise With the Launch of Expanded Services for MSK Direct Members
Memorial Sloan Kettering Cancer Center (MSK) today announced the launch of a new digital patient experience through MSK Direct, a national cancer benefits solution for self-insured employers, labor unions, and health plans. With this launch, MSK Direct members will have seamless access through the MSK Direct app to virtual cancer support services, including expert medical opinions and 24/7 cancer care coaching and navigation.
Memorial Sloan Kettering Cancer Center Statement on Affirmative Action
“The recent ruling by the Supreme Court in the cases of Students for Fair Admissions Inc. v. President and Fellows of Harvard College and Students for ...
Shelly Anderson, MPM
Shelly Anderson Named Memorial Sloan Kettering Cancer Center’s Inaugural Hospital President
Memorial Sloan Kettering Cancer Center (MSK) today announced that Shelly Anderson, MPM, will join the institution as the inaugural Hospital President on September 25. Anderson joins MSK from Brigham and Women’s Hospital (BWH) in Boston, where she has been a member of the executive leadership team since 2011, most recently serving as Executive Vice President and Chief Operating Officer.
MSK Awards & Appointments January 2023
MSK Awards & Appointments June 2023
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Deb Schrag
ASCO 2023: New Research from Memorial Sloan Kettering Cancer Center and Dana-Farber Brigham Cancer Center Finds that Radiation Can Be Safely Omitted in Select Patients with Locally Advanced Rectal Cancer
Deb Schrag, MD, MPH, gastrointestinal oncologist and Chair of the Department of Medicine, presented results from a randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total surgical excision for the treatment of patients with locally advanced rectal cancer.
Ingo Mellinghoff
ASCO 2023: New Research from Memorial Sloan Kettering Cancer Center Identifies Significant Treatment Advancement for Brain Tumors
Ingo K. Mellinghoff, MD, FACP, neuro-oncologist and Chair of the Department of Neurology, presented significant results from a phase III trial in patients with residual or recurrent grade 2 glioma with an IDH1/2 mutation.
MSK Awards & Appointments January 2023
MSK Awards & Appointments May 2023
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.